• 1gutenburg

    by John Bennett MD

    October 23, 2015

    Yeah, I know you must be saying, Dr. Bennett, can’t you give this Hangout thing a rest, and get a hobby, or something?

    We are having our first “Hangout Publishing” Hangout tomorrow night, Friday at 9 pm, to hangout with Medical writer, John Hewitt, from Philadelphia, at www.NeurologyWeb.TV

    It is about an article he just published yesterday,

    Transparent optogenetic brain implants: Yet another amazing use for graphene“.  If you want to be on the panel for it, email me at desertedbeach@hotmail.com.

    Well, I am tremendously excited by the possibilities of this platform.  To communicate, to network, and to educate.  Hell, I met a couple of young whippersnapper Med Students from Tufts last night, that showed me the future of Medical care in the USA is in good hands; compassionate, patient, tech-smart, and, most of all, treat geezer MDs like me with respect. (By the way, I have already bought the domain name, geezermd.com, so don’t go lookin for it)

    Anyways.we made progress from the old Printing press with faster transmission of the news with radio and television.  Then came the computer.  Superfast publication.

    But hangouts can let us add another valuable layer to reading of Digital Healthcare happenings; it allows for INTERACTION with the author of the article, almost in REAL TIME,  as well as some damn good networking.  Maybe even include some of the doctors, researchers, web people mentioned in the article.

    It is like you are watching your favorite TV show, and you can stop the show and engage the actors you are watching in real time.  Or tweet them questions, if not in the panel.

    Let’s just say, in summation, Hangouts adds a level of immediacy to the interaction about the particular topic, as well as perhaps the most valuable aspect; human interaction.

     
     

    No comments

    Be the first one to leave a comment.

    Post a Comment


     

     

    Latest Posts

    Latest Video

     
     

    LATEST POSTS

    Chinese company Jala Group using 3D printed skin to test cosmetics for Asian market

    SOURCE Jala Group, a Chinese cosmetics company, has used 3D bioprinting technology to print artificial “Asian skin,” complete with dermis and…

    Historic HIV vaccine efficacy study underway in South Africa

    The first HIV vaccine efficacy study to launch anywhere in 7 years is testing whether an experimental vaccine safely prevents…

    When Pot Meets Pain and Insomnia: Why Many Fibromyalgia Patients Swear by Medical Marijuana

      Fibromyalgia is a painful condition that over three million Americans suffer from. It causes widespread muscle pain and tenderness…

    Nanoarray sniffs out and distinguishes multiple diseases

    SOURCE “Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules” ACS Nano Before modern…

    Cardiac stem cell infusion could be effective therapy for the most common type of heart failure

    SOURCE Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new…

    Outer layer of human heart regrown using stem cells

    Human stem cells have been used to regenerate the cells that cover the external surface of a human heart(Credit: DarioStudios/Depositphotos) SOURCE…

    Gastrogenomic delights: A movable feast

    SOURCE The complete genome sequences of Escherichia coli and Helicobacter pylori provide insights into the biology of these species Recently,…

    Glaucoma gene therapy on positive trajectory using CRISPR-Cas9

    SOURCE May 02, 2016 Seattle—Results from a series of preclinical studies are providing proof of principle that gene targeting using…